Educational research tool. Not investment advice. You are responsible for your own trading decisions.

Verdix.
← All analysis

ServiceNow, Inc. (NOW)

4 analyses published — select a date to read that version.

Verdict history · NOW

VerdictPublishedPeriod return
WAITJun 11, 2026 · $104.46-11.4%
BUYJun 13, 2026 · $92.57+16.4%
BUYJul 11, 2026 · $107.71-4.2%
WAITJul 18, 2026 · $103.24Active

Period return = price change from verdict date to next verdict date (or present for Active). Prices are from published frontmatter — a stated fact, not a live feed. See methodology for how verdicts are produced. Full track record →

changed
changed

Hold NOW with conviction. Here’s why the panel thinks it’s a WAIT, and where they disagree.

WAITMEDIUM confidence

A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.

NYSE · Enterprise Software (SaaS) · 2026-07-18 · analysis, not advice

Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 103.24 (as of 2026-07-18) · Changed from BUY

What changed since 2026-07-11:

  • Price: USD 107.71 → 103.24 (-4.1%) — a spike to $138-141 failed to hold the $123 resistance zone and round-tripped back down to retest $100-103.
  • Panel: 3 of 6 → 2 of 6 now Bullish (the Intrinsic-Value Modeler flipped from Bullish to Neutral) — the DCF case now wants the July 22 print to confirm the discount before calling it a buy.
  • Trigger: the Q2 earnings print on July 22, or a volume-backed close back above the $123 resistance zone.
  • Verdict: BUY → WAIT

ServiceNow's business case remains undisputed across all six lenses — 22% subscription growth, 97-98% renewal, and a Now Assist target raised to $1.5B, none of which has moved since last week. What tipped the synthesis from BUY to WAIT is that the tape still hasn't confirmed the story: two lenses treat the pullback as noise around an already-actionable mispricing, while four want the July 22 print or a volume-backed reclaim of $123 before committing fresh capital — a price-and-timing debate, not a business-quality one.

Key levels

Key levels · NOW

USD · as of 2026-07-18
Analyst consensus 143
R3160
+55.0%
R2143
+38.5%
R1123
+19.1%Failed reclaim zone — confirmation trigger on volume
S1100
−3.1%Historical accumulation zone — this week's retest
S290
−12.8%Prior capitulation low
S378
−24.4%
NOW
103.24

Analyst consensus target 143 USD · range 85236

Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.

Key resistance starts at ~$123 — the level the stock spiked through to $138-141 two weeks ago and then failed to hold, making it the level several lenses now treat as the confirmation trigger — then ~$143-145 (also near the analyst-consensus average), up to the ~$160 shelf. Key support sits at ~$100, a round number this week's retreat is retesting directly, then ~$90 (the prior capitulation low), with a deeper structural level near ~$78-80. The analyst consensus target still spans a wide USD 85 to 236, averaging near USD 143 — roughly 38% above the current price.

What legendary investors think

We ran ServiceNow past a panel of six legendary investors' frameworks.

The panel · 6 investors

🟢
2
Bullish
4
Neutral
🔴
0
Bearish
The Moat CompounderValue/Quality/Moat NeutralMedium

Renewal at 97-98%, 22% subscription growth, net cash, and 13-16% ROE aren't the marks of a broken company — "a 53% de-rating on a story the operating results never confirmed does smell like Mr. Market being emotional." But with the stock still below its own Supertrend line at $103 and the $123 reclaim already failed once, he won't commit fresh capital into the binary of a July 22 print four days out.

The GARP OperatorGrowth (GARP)🟢 BullishMedium

Subscription revenue +22%, cRPO +21% cc, 97-98% renewal, and the Now Assist target raised $1.0B→$1.5B — "a company growing, not one being killed by AI." A PEG near 0.80 at 19.8x forward earnings, net cash of $5.5B, D/E of 0.21, and $1.665B of quarterly free cash flow is a mismatch he'd rather own now than wait on: "the chart just tells me Mr. Market hasn't done his homework yet."

The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMedium

The AI-platform economics are accelerating even as the market priced in an "AI kills SaaS" narrative the data doesn't support — subscription +22%, cRPO +21% cc, $1M+ ACV customers +130% YoY. On a PEG of 0.80 and EV/FCF of 18x against 44% FCF margins, "this is a platform compounder trading like a melting ice cube," and the failed breakout to $138-141 reads as weak hands shaking out before the July 22 catalyst confirms the thesis already visible in the numbers.

The Intrinsic-Value ModelerValuation/DCF NeutralMedium

The 22% subscription growth and 97-98% renewal "simply don't support a stock that fell 53% peak to trough," but at $103.24 with EV/sales still near 7.1x and a trailing GAAP P/E north of 51x, the tape isn't handing him the discount its own chart pattern implies. The failed breakout above $123 and round-trip to retest $100 tells him "price is waiting for the July 22 print, and so should my conviction."

The Forensic SkepticContrarian/Forensic NeutralLow

"The footnotes haven't been written yet" — every number in this brief is a Q1 carry-forward four days ahead of the print. The setup is real (97-98% renewal, cRPO +21% cc, EV/FCF ~18x against $5.5B net cash isn't expensive if growth holds), but he won't pay for a thesis before the data that tests it: "this is a WAIT, not a BUY — get the print, get a close back above $123 on volume, then size up."

The Macro OpportunistMacro/Timing NeutralLow

Fundamentals — 22% subscription growth, 21% cRPO, 97-98% renewal — are fine, but "fine fundamentals with a broken chart is exactly the setup where I get run over if I size up before the tape confirms." Supertrend stays bearish below $130 after the failed reclaim of $123; he'd rather lose the first 10% of a confirmed move than front-run a binary Q2 print, and turns aggressive only on a post-earnings close above $123 on volume.

Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.

Where they agree — and where they clash

Common ground

  • The operating business is unanimously fine: subscription revenue +22% YoY, cRPO +21% cc, renewal 97-98%, net cash $5.5B, and the Now Assist agentic-AI target raised from $1.0B to $1.5B — none of the six lenses dispute these figures.
  • The chart has not confirmed the fundamental story: the spike to $138-141 failed to hold, the $123 reclaim reversed, and the stock is back retesting $100-103, still below its Supertrend line near $130.
  • The July 22 Q2 print is the shared reference point every lens is measuring against, bullish or not.

The real debate

  • Act now on the mispricing, or wait for the tape to agree? The GARP Operator and Disruptive-Innovation Seeker see a PEG near 0.80 on a 20%+ grower as already actionable; the Moat Compounder, Intrinsic-Value Modeler, Forensic Skeptic, and Macro Opportunist all want either the earnings print or a volume-backed reclaim of $123 first.
  • Is this price/timing hesitation, or a change in business view? None of the four neutral voices point to a deteriorating metric — their reasoning is explicitly about the binary event risk and the failed breakout, not the renewal rate or the growth numbers.

The question it comes down to: With the business case unchanged and unanimous, does the failed $123 reclaim and four days to a binary earnings print argue for waiting on confirmation, or is the PEG-near-0.80 mismatch already wide enough that waiting just means paying up later?

The numbers

Metric Value
Price / Market cap USD 103.24 / n/a
P/E (fwd / trailing GAAP) ~19.8x / ~51x
Subscription revenue growth +22% YoY (Q1'26)
cRPO +21% cc
Renewal rate 97–98%
ROE 13–16%
Now Assist ACV target Raised USD 1.0B → 1.5B for 2026; $1M+ ACV customers +130% YoY
Balance sheet Net cash ~USD 5.5B; D/E 0.21
Free cash flow USD 1.665B (Q1'26)
Valuation EV/sales ~7.1x; EV/FCF ~18x; PEG ~0.80

Figures as of Q1 2026 (reported ~Apr 22-23) carried forward to July 18, 2026, four trading days ahead of the Q2 print scheduled July 22, 2026; sourced from ServiceNow IR/SEC filings, Investing.com, StockAnalysis, MarketBeat, GuruFocus.

The bottom line

The July 22 print is the fulcrum: another quarter of 20%+ subscription growth with renewal and cRPO intact, paired with a volume-backed close back above $123, would likely convert the four neutral lenses into buyers and could re-open a BUY call within days. Conversely, any crack in renewal (below 94-95%) or a second failed attempt at $123 would harden the neutral stance into an extended WAIT rather than resolve it quickly. Watch the $100 support directly below current price — a decisive break would test the prior capitulation low near $90 before the earnings data even arrives.

contact@verdixhq.com · Published 2026-07-18 · Prices as of 2026-07-18 · Time horizon: 3–12 months · Founder holds a direct position in NOW · NOW verdict history → · Methodology →

Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.

Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.

Follow NOW

Get an email when the panel's verdict on NOW changes.

No spam. Unsubscribe anytime.